Pioglitazone increases circulating adiponectin levels and subsequently reduces TNF‐α levels in Type 2 diabetic patients: a randomized study
Authors:
- 16 February 2006
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 23 (3) , 253-257
Abstract
Background Adipocytokines are involved in the development of insulin resistance and endothelial dysfunction in diabetic patients. However, the relationship between these factors remains unclear. We observed a chronological change in circulating adipocytokines and blood pressure levels with administration of oral hypoglycaemic agents in Type 2 diabetic (T2DM) subjects.Methods Thirty poorly controlled T2DM subjects (aged 60.1 ± 1.5 years, 11 males and 19 females) were randomized into two groups: voglibose (initial dose 0.6 mg/day, increased to 0.9 mg/day) and pioglitazone (initial dose 15 mg/day, increased to 30 mg/day).Results Both treatment groups showed a similar improvement in glycaemic control. In pioglitazone‐treated patients, circulating adiponectin levels were significantly increased from 4 weeks after the start of treatment, and until the end of the study at 12 weeks. Plasma tumour necrosis factor‐α (TNF‐α) levels were significantly decreased only at 12 weeks. In contrast, no significant changes in plasma adiponectin or TNF‐α levels were observed in voglibose‐treated patients. Plasma PAI‐1 and leptin levels were not significantly changed at 12 weeks in either treatment group. Pioglitazone significantly decreased systolic and diastolic blood pressure levels at 12 weeks, but voglibose had no effect.Conclusion In summary, pioglitazone caused an immediate increase in circulating adiponectin levels, followed by a reduction of TNF‐α. The observed increase in circulating adiponectin could be related to decreases in both systolic and diastolic blood pressure.Keywords
This publication has 26 references indexed in Scilit:
- Effect of Pioglitazone on Circulating Adipocytokine Levels and Insulin Sensitivity in Type 2 Diabetic PatientsThe Journal of Clinical Endocrinology & Metabolism, 2004
- The Role of TNF-α in Insulin ResistanceEndocrine, 2004
- Association of Hypoadiponectinemia With Impaired VasoreactivityHypertension, 2003
- Effects of pioglitazone on metabolic control and blood pressure: a randomised study in patients with type 2 diabetes mellitusCurrent Medical Research and Opinion, 2003
- Rosiglitazone reduces urinary albumin excretion in type II diabetesJournal of Human Hypertension, 2003
- Effects of Pioglitazone in Nondiabetic Patients with Arterial Hypertension: A Double-Blind, Placebo-Controlled StudyThe Journal of Clinical Endocrinology & Metabolism, 2002
- Hormonal Regulation of Adiponectin Gene Expression in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 2002
- Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individualsDiabetologia, 1998
- Effects of Leptin on Insulin Sensitivity in Normal RatsEndocrinology, 1997
- Positional cloning of the mouse obese gene and its human homologueNature, 1994